21 CFR Part 878 · General and Plastic Surgery Devices

21 CFR 878.4810

Laser surgical instrument for use in general and plastic surgery and in dermatology

21 CFR 878.4810 is the regulation titled “Laser surgical instrument for use in general and plastic surgery and in dermatology” in 21 CFR Part 878, General and Plastic Surgery Devices. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 807.81, in 1 letter
Closed out
100% of these letters have a published close-out
See the letter citing 21 CFR 878.4810 →

Letters citing it, by year issued

It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 12022
  3. 02023
  4. 02024
  5. 02025
  6. 02026

What FDA writes when it cites it

The finding headings that cite 21 CFR 878.4810 most often, as written in the letters.

  • 1 letterFDA has reviewed your firm’s website (www.skinsheek.com) and determined that the SILK is adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because your firm does not have an approved…

The regulation

Read the text of 21 CFR 878.4810 (eCFR, as of Sep 1, 2026)

(a) Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.

(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

(b) Classification. (1) Class II.

(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

[53 FR 23872, June 24, 1988, as amended at 61 FR 1123, Jan. 16, 1996; 66 FR 38803, July 25, 2001]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 878.4810.

Latest letters citing it

The letter citing 21 CFR 878.4810 that FDA posted most recently.

See the letter citing 21 CFR 878.4810 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.